Cardinal Health Inc.’s stock rose 9% early Wednesday, after the drug distributor and medical products maker beat estimates for its fiscal fourth quarter and raised its guidance.
[stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="NYSENasdaq" width="100%" palette="financial-light"]
